Cancer Drug Encyclopedia
Approved oncology medications — what they treat, how they work and key safety information.
Advanced Prostate Cancer and Premenopausal Hormone-Receptor Positive Breast Cancer.
Approved for use in oncology care according to FDA-approved indications.
Melanoma, Non-Small Cell Lung Cancer, Renal Cell Carcinoma, Urothelial Cancer, Head and Neck Cancer, MSI-H/dMMR solid tumors, and Cervical Cancer.
Relapsed or refractory B-cell Acute Lymphoblastic Leukemia, Large B-cell Lymphoma, Mantle Cell Lymphoma, or Multiple Myeloma.
Relapsed or refractory B-cell Acute Lymphoblastic Leukemia, Large B-cell Lymphoma, Mantle Cell Lymphoma, or Multiple Myeloma.
Brain Tumors (Glioblastoma, Astrocytoma), Multiple Myeloma, Lymphomas, Leukemias, Sarcomas, and conditioning regimens.
Advanced or metastatic solid tumors or hematologic malignancies expressing targeted surface antigens.
Colorectal, Pancreatic, Breast, Non-Small Cell Lung Cancer, Myelodysplastic Syndromes (MDS), and Acute/Chronic Leukemias.
Melanoma, Non-Small Cell Lung Cancer, Renal Cell Carcinoma, Urothelial Cancer, Head and Neck Cancer, MSI-H/dMMR solid tumors, and Cervical Cancer.
ALK-positive and ROS1-positive metastatic Non-Small Cell Lung Cancer.
ALK-positive and ROS1-positive metastatic Non-Small Cell Lung Cancer.
KRAS G12C-mutated Non-Small Cell Lung Cancer and advanced Colorectal Cancer.